PULSE BIOSCIENCES, INC. - 8-K Filing

Pulse Biosciences surpasses enrollment midpoint in NANOPULSE-AF clinical study for nPulse Cardiac Catheter System. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $PLSE

Read the full article at SEC EDGAR

More Regulatory news